Using advanced deep learning to analyze biological sequences
Multi-view self-supervised deep learning for biological sequences and beyond
This study is working on new computer programs that can better understand and predict the building blocks of life, like DNA and proteins, which could help create more personalized treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10895278 on NIH RePORTER |
What this research studies
This research focuses on developing innovative deep learning algorithms to analyze and predict biological sequences, such as DNA and protein structures. By utilizing self-supervised learning techniques, the project aims to improve the accuracy and efficiency of biological data analysis without relying on extensive human-labeled data. The Xu lab has already produced numerous publications and open-source tools that contribute to drug design and molecular biology, making significant strides in the field of bioinformatics. Patients may benefit from advancements in personalized medicine and targeted therapies resulting from these analyses.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with genetic disorders or those requiring targeted therapies based on their unique biological makeup.
Not a fit: Patients with conditions that do not involve genetic or molecular factors may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatments for various diseases by improving our understanding of biological sequences.
How similar studies have performed: Other research has shown success with similar deep learning approaches in biological analysis, indicating a promising avenue for further exploration.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Xu, Dong — University of Missouri-Columbia
- Study coordinator: Xu, Dong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.